Cite
HARVARD Citation
Argilés, G. et al. (2022). A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). European journal of cancer. pp. 154-163. [Online].